Cargando…

Saliva Liquid Biopsy for Point-of-Care Applications

Saliva is a non-invasive biofluid, which is easy to collect, transport, and store. Because of its accessibility and connection to systemic diseases, saliva is one of the best candidates for the advancement of point-of-care medicine, where individuals are able to easily monitor their health status by...

Descripción completa

Detalles Bibliográficos
Autores principales: Aro, Katri, Wei, Fang, Wong, David T., Tu, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5387045/
https://www.ncbi.nlm.nih.gov/pubmed/28443278
http://dx.doi.org/10.3389/fpubh.2017.00077
_version_ 1782520866367602688
author Aro, Katri
Wei, Fang
Wong, David T.
Tu, Michael
author_facet Aro, Katri
Wei, Fang
Wong, David T.
Tu, Michael
author_sort Aro, Katri
collection PubMed
description Saliva is a non-invasive biofluid, which is easy to collect, transport, and store. Because of its accessibility and connection to systemic diseases, saliva is one of the best candidates for the advancement of point-of-care medicine, where individuals are able to easily monitor their health status by using portable convenient tools such as smartphones. There are a variety of scenarios with which saliva can be used: studies have been conducted on using saliva to measure stress hormones, enzyme levels, developmental disease biomarkers, and even cancer mutations. If validated biomarkers were combined with high-quality detection tools, saliva would open up a new frontier in high-quality healthcare, allowing physicians and patients to work together for real-time health monitoring and high-impact personalized preventative medicine. One of the most exciting emerging frontiers of saliva is liquid biopsy, which is a non-invasive means to assess the presence and characteristics of cancer in a patient. This article will review current basic knowledge of biomarkers, review their relation to different diseases and conditions, and explore liquid biopsy for point-of-care applications.
format Online
Article
Text
id pubmed-5387045
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-53870452017-04-25 Saliva Liquid Biopsy for Point-of-Care Applications Aro, Katri Wei, Fang Wong, David T. Tu, Michael Front Public Health Public Health Saliva is a non-invasive biofluid, which is easy to collect, transport, and store. Because of its accessibility and connection to systemic diseases, saliva is one of the best candidates for the advancement of point-of-care medicine, where individuals are able to easily monitor their health status by using portable convenient tools such as smartphones. There are a variety of scenarios with which saliva can be used: studies have been conducted on using saliva to measure stress hormones, enzyme levels, developmental disease biomarkers, and even cancer mutations. If validated biomarkers were combined with high-quality detection tools, saliva would open up a new frontier in high-quality healthcare, allowing physicians and patients to work together for real-time health monitoring and high-impact personalized preventative medicine. One of the most exciting emerging frontiers of saliva is liquid biopsy, which is a non-invasive means to assess the presence and characteristics of cancer in a patient. This article will review current basic knowledge of biomarkers, review their relation to different diseases and conditions, and explore liquid biopsy for point-of-care applications. Frontiers Media S.A. 2017-04-11 /pmc/articles/PMC5387045/ /pubmed/28443278 http://dx.doi.org/10.3389/fpubh.2017.00077 Text en Copyright © 2017 Aro, Wei, Wong and Tu. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Public Health
Aro, Katri
Wei, Fang
Wong, David T.
Tu, Michael
Saliva Liquid Biopsy for Point-of-Care Applications
title Saliva Liquid Biopsy for Point-of-Care Applications
title_full Saliva Liquid Biopsy for Point-of-Care Applications
title_fullStr Saliva Liquid Biopsy for Point-of-Care Applications
title_full_unstemmed Saliva Liquid Biopsy for Point-of-Care Applications
title_short Saliva Liquid Biopsy for Point-of-Care Applications
title_sort saliva liquid biopsy for point-of-care applications
topic Public Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5387045/
https://www.ncbi.nlm.nih.gov/pubmed/28443278
http://dx.doi.org/10.3389/fpubh.2017.00077
work_keys_str_mv AT arokatri salivaliquidbiopsyforpointofcareapplications
AT weifang salivaliquidbiopsyforpointofcareapplications
AT wongdavidt salivaliquidbiopsyforpointofcareapplications
AT tumichael salivaliquidbiopsyforpointofcareapplications